Moderna, Inc. (MRNA)
226.11
+8.10
(+3.72%)
USD |
NASDAQ |
Oct 19, 14:03
Moderna Cash from Operations (Annual) : -1.873B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.873B |
| December 31, 2024 | -3.004B |
| December 31, 2023 | -3.118B |
| December 31, 2022 | 4.981B |
| December 31, 2021 | 13.62B |
| Date | Value |
|---|---|
| December 31, 2020 | 2.027B |
| December 31, 2019 | -458.00M |
| December 31, 2018 | -330.86M |
| December 31, 2017 | -331.48M |
| December 31, 2016 | 66.73M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Revolution Medicines, Inc. | -897.74M |
| Vaxcyte, Inc. | -655.58M |
| Twist Bioscience Corp. | -47.63M |
| BioNTech SE | 514.63M |
| Vir Biotechnology, Inc. | -391.78M |